Reporting and representation of participant race and ethnicity in phase III clinical trials for solid tumors
Background Including racial and ethnic minorities in clinical trials is essential for advancing health equity. Despite progress, trials often do not mirror patient population demographics.Methods The National Library of Medicine’s Clinical Trials database was queried for phase III trials of lung, co...
Saved in:
| Main Authors: | Tianyi Wang, Dinorah J Villanueva, Ambily Banerjee, Dina Gifkins |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20565623.2025.2458415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reporting of Race, Ethnicity, and Ancestry Remains Inadequate in Kidney Research
by: Jian Roushani, et al.
Published: (2024-11-01) -
Neighborhood racial/ethnic composition and depressive symptoms of later life: The moderation effects of individual race/ethnicity
by: Seungjong Cho, Ph.D., et al.
Published: (2025-03-01) -
Percutaneous Coronary Intervention Outcomes by 5 Major Race and Ethnic Subgroups
by: Arjun B. Kapoor, MD, et al.
Published: (2025-06-01) -
Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
by: Tsuyoshi Baba
Published: (2025-01-01) -
Contribution of chronic conditions to mortality: Differences by race and ethnicity
by: Miriam R. Elman, et al.
Published: (2025-06-01)